Isotechnika Partner Files for Approval of Voclosporin in US, Europe

Isotechnika Pharma Inc. Thursday announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application with the U.S. Food and Drug Administration and a Market Authorization Application with the European Medicines Agency for voclosporin, under the proposed brand name, LUVENIQ.
CNW Group